|
Report No. : |
357011 |
|
Report Date : |
30.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
SHENG CHUN TANG PHARMACEUTICAL INDUSTRIAL
CO., LTD. |
|
|
|
|
Registered Office : |
No.6, Singgong Rd., Yongkang Dist., Tainan City
710, Taiwan (R.O.C.) |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
07.10.1982 |
|
|
|
|
Com. Reg. No.: |
73701535 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturing and Sales of Medical Products. |
|
|
|
|
No. of Employees : |
About 300 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Taiwan |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
TAIWAN - ECONOMIC OVERVIEW
Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are other major long-term challenges.
Free trade agreements have proliferated in East Asia over the past several years. Following the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, Taiwan in July 2013 signed a free trade deal with New Zealand - Taipei’s first-ever with a country with which it does not maintain diplomatic relations - and, in November, inked a trade pact with Singapore. However, follow-on components of the ECFA, including a signed agreement on trade in services and negotiations on trade in goods and dispute resolution, have stalled. In early 2014, the government bowed to public demand and proposed a new law governing the oversight of cross-Strait agreements, before any additional deals with China are implemented; the legislature has yet to vote on such legislation, leaving the future of ECFA up in the air as President MA enters his final full year in office. MA has portrayed ECFA as Taiwan’s key to greater participation in East Asia’s free trade networks.
Taiwan's total fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 expected to account for nearly 20% of the island's total population by 2025.
The island runs a trade surplus, largely because of its surplus with China, and its foreign reserves are the world's fifth largest, behind those of China, Japan, Saudi Arabia, and Switzerland. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Taiwan since 2009 has gradually loosened rules governing Chinese investment on the island and has also secured greater market access for its investors in the mainland. In August 2012, the Taiwan Central Bank signed a memorandum of understanding (MOU) on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which has helped Taiwan develop into a local RMB hub.
Closer economic links with the mainland bring greater opportunities for Taiwan’s economy but also pose new challenges as the island becomes more economically dependent on China at a time when political differences remain unresolved. During 2014, the press paid increasing attention to domestic economic issues, while pushing aside the debates over trade liberalization that were a hallmark of MA’s tenure. The media focused on the divide between Taiwan’s “haves” and “have nots,” providing extensive coverage of public frustration with stagnant wages, skyrocketing housing prices, and the difficulty of finding decent entry-level jobs.
|
Source
: CIA |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
No.6, Singgong
Rd., Yongkang Dist., Tainan City 710, Taiwan (R.O.C.) |
|
Supplied Address: |
|
|
Telephone Number: |
+886-6-232-5155 |
|
Fax Number: |
Notes: The exact name and address are as above.
Subject was incorporated
on 1982-10-7 with registered number 73701535
as Joint Stock Company in Taiwan.
Factory
|
Address: |
No.6, Singgong Rd., Yongkang Dist., Tainan
City 710, Taiwan (R.O.C.) |
|
Date of Foundation: |
1982-8-21 |
|
Date of Registration: |
1983-8-25 |
|
Factory Registration Number: |
99659604 |
|
Factory Manager: |
Meixun Wang |
|
Status: |
In Production |
|
Date of Last Annual Return: |
2015-1-25 |
|
Major Products: |
200 Medicine and medical chemical products. 193 Cleaning supplies. 194 Cosmetics 092 Non-alcoholic beverage 089 Other food |
Major Related
Company
|
Name: |
Likang Biotechnical Co. Ltd. |
|
Address: |
No. 29, Huanggong Rd., Yongkang Dist.,
Tainan City, Taiwan |
|
Tel.: |
+886-6-233-5356 |
|
Fax: |
+886-6-202-2688 |
Major Shareholders
|
Name |
Subscription Shares |
|
Meixun Wang |
317,000 |
|
Zhiwen Zheng |
1,333,000 |
|
Yuxiu Zheng |
1,225,200 |
|
Jingying Zheng |
1,238,600 |
Core Management
Directors
|
1 |
||
|
Name |
Meixun Wang |
|
|
Position |
Board Chairman |
|
|
2 |
||
|
Name |
Zhiwen Zheng |
|
|
Position |
Director |
|
|
3 |
||
|
Name |
Yuxiu Zheng |
|
|
Position |
Director |
|
|
4 |
||
|
Name |
Jingying Zheng |
|
|
Position |
Director |
|
|
5 |
||
|
Name |
Youlin Zhuang |
|
|
Position |
Supervisor |
|
Personnel Structure
|
Total Employees |
About 300 employees |
Offices & Factories
|
|
Headquarters |
|
Add |
No.6, Singgong Rd., Yongkang Dist., Tainan City 710, Taiwan (R.O.C.) |
Production Information
Subject is engaged in manufacturing of medical products.
Subject has a factory in Tainan City, Taiwan for production.
Subject has obtained the certification of ISO 17025.
Purchase Information
The registered activities of subject:
|
Business Code |
Details |
|
C802051 |
Manufacturing of Chinese traditional medicine. |
|
F108011 |
Wholesales of Chinese traditional medicine. |
|
F208011 |
Retails of Chinese traditional medicine. |
|
F108021 |
Wholesales of Western medicine. |
|
F208021 |
Retails of Western medicine. |
|
C199990 |
Manufacturing of other classified food. |
|
C802100 |
Manufacturing of cosmetics. |
|
F108040 |
Wholesales of cosmetics. |
|
F208040 |
Retails of cosmetics. |
|
C802090 |
Manufacturing of cleaning supplies. |
|
F107030 |
Wholesales of cleaning supplies. |
|
F207030 |
Retails of cleaning supplies. |
|
C110010 |
Manufacturing of drinks |
|
F102040 |
Wholesales of drinks |
|
C802080 |
Manufacturing of environmental medicine. |
|
C802990 |
Manufacturing of other chemical products. |
|
C109010 |
Manufacturing of condiment. |
|
F102180 |
Manufacturing of alcohol. |
|
F203030 |
Retails of alcohol. |
|
F103010 |
Wholesales of feedings. |
|
F106020 |
Wholesales of daily supplies. |
|
F106060 |
Wholesales of pet products. |
|
F107070 |
Wholesales of animal medicine. |
|
F207070 |
Retails of animal medicine. |
|
F108031 |
Wholesales of medical equipment. |
|
F208031 |
Retails of medical equipment. |
|
F201020 |
Retails of animal products. |
|
F208050 |
Retails of class-B medicine. |
|
F401010 |
International trading business. |
|
ZZ99999 |
Besides licensed business, all other business items those are not
banned or restricted. |
Subject’s purchases raw material from both home and abroad.
It is introduced that subject imports some equipment from Japan.
It is introduced that subject has obtained the certification of
ISO17025/TAF.
It is introduced that subject can produce about 300,000 pieces of patch
per day.
Subject is engaged in sale of medical products.
The major products sold by the subject are herbal pain relief patch, including
medicated patch, water-based patch, oil patch, Chinese herbal medicine
medicament and so on.
It is introduced that subject can provide OEM and ODM services.
Subject’s sales regions include Mainland China, United States,
Australia, New Zealand, Mainland China, India, Southeast Asia, United Arab
Emirates and Canada,.
Subject’s major customers are pharmaceutical companies and wholesalers
of Pharmaceuticals, etc.
Subject’s major customers are Albert Max, Inc. and Topwin Trading Co., Ltd.
Import and export right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase
|
Products |
Raw materials |
|
Payment Terms |
Cash, T/T |
Import
|
Products |
Raw materials |
|
Payment Terms |
L/C, T/T |
Sales
Domestic Markets
|
Product |
Medical products |
|
Selling Terms |
Cash, T/T |
Export
|
Product |
Medical products |
|
Selling Terms |
L/C, T/T |
Subject has no obligations to disclose its financial
statements to the third party according to the relevant policy in Taiwan and
the only source from which we can obtain the information is the subject itself.
Subject’s relevant staff declined to disclose
its financials citing the grounds of company’s confidentiality; from other
sources we could not obtain such information, either.
Subject declined to disclose its bank details; from other source we
could not obtain the relevant information, either.
Mortgage
|
Case Type: |
Chattel Mortgage |
|
Registered Number: |
JS(Z)DZD102189 |
|
Debtor Name: |
Sheng Chun Tang Pharmaceutical Industrial
Co., Ltd. |
|
Registry: |
Economic Development Board of Tainan City Government |
|
Name of Mortgagee: |
Taiwan Business Bank Co., Ltd. Chenggong
Branch |
|
Date of Registration: |
2010-12-2 |
|
Amount of Secure Claims: |
NTD 8,770,000 |
|
Type of Mortgage: |
Machinery, equipment or tools |
Note: Recently, the registry of Taiwan has updated its official system of
mortgage, the form and content of the company mortgage has been changed. We can
only obtain the mortgage in new form as above for your reference.
Lawsuit
Up to date of reporting, no existing or latent
litigation of the subject has been found.
Interview Details
|
Name |
Ms. Yang |
|
Department |
Sales Department |
|
Email |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.37 |
|
|
1 |
Rs.98.91 |
|
Euro |
1 |
Rs.72.85 |
|
TWD |
1 |
Rs.2.02 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.